Standard Operating Procedure for Regulatory Review of Product Labels and Cartons
| Department | Regulatory Affairs |
| SOP No. | RA/2026/744 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 15/04/2026 |
| Effective Date | 15/04/2026 |
| Review Date | 15/04/2028 |
Purpose
This Standard Operating Procedure (SOP) aims to establish a uniform and rigorous process for the regulatory review of product labels and cartons to ensure compliance with applicable regulatory requirements, company policies, and quality standards. It supports the control objective of preventing labeling errors, ensuring accuracy and completeness of all product information, and maintaining regulatory compliance in labelling and packaging materials prior to product release.
Scope
This SOP applies to all regulatory affairs personnel and related departments involved in the review and approval of product labels and cartons for pharmaceutical products across all functional areas including manufacturing, quality assurance, quality control, and packaging. It covers review activities for all dosage forms and container types intended for domestic and international markets. This procedure excludes the physical printing of labels and cartons and focuses solely on the regulatory review and approval process.
Responsibilities
- Regulatory Affairs Team: Responsible for conducting the regulatory review of product labels and cartons for compliance with applicable regulations and internal standards.
- Quality Assurance (QA): Supervises the review process and provides the final approval ensuring adherence to quality systems.
- Labeling Coordinators/Artwork Team: Provide accurate artwork files and label content for review and implement corrections as directed.
- Document Control: Ensures proper version control and maintains records of reviewed and approved label and carton documents.
- Manufacturing/Packaging Departments: Collaborate with regulatory affairs for any label-related clarifications or deviations.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, periodic review, compliance, escalation, and overall effectiveness of this SOP in ensuring error-free and regulation-compliant labeling and carton review processes.
Procedure
The regulatory review of product labels and cartons shall follow these detailed steps to ensure accuracy, compliance, and traceability throughout the lifecycle of the labeling process:
1. Preparation and Prerequisites:
- Obtain the latest draft artwork or label files from the artwork team, accompanied by all relevant regulatory guidelines and product documentation (e.g., marketing authorization, product specifications, and previous label versions).
- Confirm all referenced regulatory requirements appropriate to the product’s target markets are assembled.
2. Initial Compliance Check:
- Review label and carton content including but not limited to product name, strength, dosage form, batch number placement, manufacturing and expiry dates, storage conditions, warnings, barcodes, and regulatory statements for compliance with local and international health authority requirements.
- Verify that all required statements, warnings, symbols, and logos are positioned and worded as per regulatory guidelines and corporate standards.
3. GMP and Quality Checks:
- Conduct a detailed cross-check against approved marketing authorization dossiers or submissions to ensure no unauthorized changes.
- Review for spelling errors, legibility, font sizes, color contrasts, and overall label readability according to GMP and labelling standards.
4. Interaction with Stakeholders:
- Compile observations, non-conformities, or required amendments and communicate clearly to the artwork or labeling coordinator for revisions.
- Re-review updated label files promptly to confirm corrections have been accurately implemented.
5. Final Review and Approval:
- Upon satisfactory compliance and completion of amendments, prepare and document the regulatory review report summarizing the review scope, findings, and confirmation of compliance.
- Recommend approval for label and carton release subject to QA concurrence.
- Submit documentation to QA for final sign-off prior to printing and distribution.
6. Documentation and Record Keeping:
- Maintain all review records, correspondence, signed approvals, and versions under document control for traceability and audit readiness.
- Implement version control ensuring superseded label versions are obsolete and removed from active use.
7. Handling Deviations and Escalations:
- Any non-compliance, dispute, or ambiguous regulatory requirement encountered during review shall be escalated to the Head of Regulatory Affairs for resolution.
- Document and report any deviations with follow-up corrective and preventive actions as required.
8. Periodic Review and Training:
- Review this SOP and associated processes at defined intervals or upon regulatory changes to ensure ongoing effectiveness and compliance.
- Conduct training sessions for all involved personnel on updates and good practices in label and carton regulatory review.
This structured procedure ensures a robust and compliant regulatory review process minimizing risks related to labeling errors and regulatory non-conformities across all products and markets.
Abbreviations
- GMP – Good Manufacturing Practice
- QA – Quality Assurance
- RA – Regulatory Affairs
- MA – Marketing Authorization
- QC – Quality Control
- SOP – Standard Operating Procedure
Documents
- Regulatory Label and Carton Review Checklist (Annexure-1)
- Label Change Request Form (Annexure-2)
- Label Review and Approval Report (Annexure-3)
References
- ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- EU Guidelines on Good Manufacturing Practice for Medicinal Products
- US FDA 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
- WHO Technical Report Series on Labeling Requirements
- Internal Document Control and Quality Management Systems
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Regulatory Label and Carton Review Checklist
Purpose: To systematically verify compliance of product labels and cartons against regulatory requirements and internal standards.
| Item | Check Description | Compliant (Yes/No) | Comments |
|---|---|---|---|
| 1 | Product Name Accuracy | Yes | – |
| 2 | Dosage Form and Strength | Yes | – |
| 3 | Batch Number Location and Format | Yes | – |
| 4 | Manufacture and Expiry Dates | Yes | – |
| 5 | Storage Conditions | Yes | – |
| 6 | Warnings and Precautions | Yes | – |
| 7 | Regulatory Statements | Yes | – |
| 8 | Barcode and Serialization | Yes | – |
| 9 | Font Legibility and Size | Yes | – |
| 10 | Artwork Version Control | Yes | – |
Annexure-2: Label Change Request Form
Purpose: To document and request approval for any changes to product labels or cartons prior to implementation.
| Request ID | LCR-0012345 |
| Date of Request | 01/04/2026 |
| Product Name | Example Drug XYZ Tablet |
| Dosage Form | Tablet |
| Proposed Change Description | Update storage condition from “Store at 25°C” to “Store below 30°C” |
| Reason for Change | Regulatory update per new guidance |
| Requested By | Regulatory Affairs Department |
| Reviewed By | |
| Approval Status | Pending |
| Comments |
Annexure-3: Label Review and Approval Report
Purpose: To document the outcome and approval status of the regulatory review of product labels and cartons.
| Report ID | RA-LR-2026-0047 |
| Product Name | Example Drug XYZ Tablet |
| Label Version | v3.2 |
| Review Start Date | 05/04/2026 |
| Review Completion Date | 12/04/2026 |
| Reviewer(s) | Regulatory Affairs Team |
| Compliance Status | Compliant |
| Remarks | No deviations noted. All regulatory requirements met. |
| Approval Signature | _________________________ |
| Date | 15/04/2026 |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 15/04/2026 | 1.0 | Initial issue | New SOP creation |